LATEST ARTICLES
UI neuroscientists receive major grant to continue work on Huntington’s disease...
$18 million NIH grant for research to understand brain development in children at risk for HD
Peg Nopoulos, MD, chair of psychiatry and professor of...
The right mouse model is crucial for Huntington’s disease drug development
Huntington's disease (HD) is an incurable and fatal hereditary disease. Developing disease-modifying drugs to treat patients with HD depends on studying them in animal...
Huntington’s Disease Patients Need Better Understanding of Risks and Benefits of...
Investigators report in JHD that Huntington’s disease patients are at risk for therapeutic misconception about clinical trials and recommend improving patient-doctor communications to ensure...
UNIVERSITY
UI neuroscientists receive major grant to continue work on Huntington’s disease...
$18 million NIH grant for research to understand brain development in children at risk for HD
Peg Nopoulos, MD, chair of psychiatry and professor of...
Ancient worm reveals way to destroy toxic cells in Huntington’s disease
Research led by a Monash University scientist has identified a highly conserved mechanism in worms and humans that controls the removal of toxic protein...
Researchers identify a molecular mechanism involved in neuronal degeneration caused by...
Researchers from the Institute of Neurosciences of the University of Barcelona (UBNeuro) and the August Pi i Sunyer Biomedical Research Institute (IDIBAPS) described a...
Researchers Identify Unique Brain Changes in People with Huntington’s Disease
The part of the brain that selectively degenerates in people with Huntington’s disease (HD), called the striatum, is almost entirely destroyed in the late...
HDBUZZ
Could molecular handcuffs lower the protein that causes Huntington’s disease?
Researchers got surprisingly lucky when looking for drug molecules to pull mutant huntingtin protein into a cellular garbage disposal machine
Several approaches are being taken...
Details emerge of first Huntington’s disease gene therapy clinical trial
UniQure announces key details of its planned trial to assess the safety and ability of AMT-130 gene therapy to lower the problematic huntingtin protein...
ARTICLES
IONIS-HTTRx
